We find that, in lung and breast carcinomas versus normal tissue, the balance between TIMP2 and these known molecular targets is clearly shifted in favor of metalloproteinase expression in tumor tissues (Fig. 1E). This evidence concerns the gene TIMP2 and breast carcinoma.